rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1999-9-23
|
pubmed:abstractText |
Tumoral angiogenesis has been described as associated with poor prognosis in breast cancer, particularly for node negative breast cancer. The purpose of this study was to evaluate the influence of angiogenesis in node-positive breast cancer and particularly its potential impact on adjuvant chemotherapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0167-6806
|
pubmed:author |
pubmed-author:BardouV JVJ,
pubmed-author:BertucciFF,
pubmed-author:BirbaumDD,
pubmed-author:CamerloJJ,
pubmed-author:GravisGG,
pubmed-author:HassounJJ,
pubmed-author:HouvenaeghelGG,
pubmed-author:JacquemierJJ,
pubmed-author:MaraninchiDD,
pubmed-author:Oziel-TaïebSS,
pubmed-author:Penault-LlorcaFF,
pubmed-author:PuigBB,
pubmed-author:ResbeutMM,
pubmed-author:ViensPP
|
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
205-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10445419-Adult,
pubmed-meshheading:10445419-Aged,
pubmed-meshheading:10445419-Algorithms,
pubmed-meshheading:10445419-Analysis of Variance,
pubmed-meshheading:10445419-Antibiotics, Antineoplastic,
pubmed-meshheading:10445419-Antineoplastic Agents,
pubmed-meshheading:10445419-Breast Neoplasms,
pubmed-meshheading:10445419-Chemotherapy, Adjuvant,
pubmed-meshheading:10445419-Female,
pubmed-meshheading:10445419-Humans,
pubmed-meshheading:10445419-Lymphatic Metastasis,
pubmed-meshheading:10445419-Middle Aged,
pubmed-meshheading:10445419-Multivariate Analysis,
pubmed-meshheading:10445419-Neoplasm Staging,
pubmed-meshheading:10445419-Neoplasms, Hormone-Dependent,
pubmed-meshheading:10445419-Neovascularization, Pathologic,
pubmed-meshheading:10445419-Prognosis,
pubmed-meshheading:10445419-Survival Analysis
|
pubmed:year |
1999
|
pubmed:articleTitle |
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy.
|
pubmed:affiliation |
Medical Oncology Department, Institut Paoli Calmettes, Université de la Méditerranée, Marseille, France. oncomed@marseille.fnclcc.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|